NH102

DRUG3 trials

Sponsors

Jiangsu Nhwa Pharmaceutical Co., Ltd.

Conditions

DepressionMajor Depressive Disorder (MDD)

Phase 1

Single Ascending Dose Study of NH102 in Healthy Subjects

CompletedNCT05015192

Jiangsu Nhwa Pharmaceutical Co., Ltd.Depression

Start: 2021-08-12End: 2022-01-11Updated: 2025-02-19

Multiple Ascending Dose Study of NH102 in Healthy Subjects

CompletedNCT07324408

Jiangsu Nhwa Pharmaceutical Co., Ltd.Depression

Start: 2022-03-10End: 2023-04-10Updated: 2026-01-07

Phase 2

A Phase II Study to Evaluate NH102 for Depression

CompletedNCT06842992

Jiangsu Nhwa Pharmaceutical Co., Ltd.Major Depressive Disorder (MDD)

Start: 2024-12-04End: 2025-09-12Updated: 2025-12-01